Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

PrEP implants are promising for HIV prevention if the number of implants needed is minimized.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

DA-9401 helps protect rat testis from finasteride damage.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

MK-386 lowers DHT in blood and skin but not in semen.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.